StocksRunner logo
search
 
menu
 
  Overview  
  
  Trending  
  
  Gainers  
  
  Losers  
  
  Volume  
  
  Earnings  
  
  Upgrades  
  
  Downgrades  
  
  Option Activity  
  
  Target Price  
  
  Indicators  
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity and Stay Ahead: Stock Market Updates, Expert Analysis, and Future Predictions

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Stay Informed with StocksRunner

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Our Services

Real-time stock market updates

Expert stock analysis

Investment strategies

Top stock recommendations

In-Depth Stock Analysis

Stock Sentiment Visualization

Daily Alerts for Stock Market Insights

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: Past performance, whether actual or indicated by historical tests, is not indicative of future success. Results are based on strategies not previously available to investors and may not reflect actual investor returns. Readiness and Sentiment Indicators, as well as the total score, are calculated using historical data and assumptions integral to the model, and they may be subject to losses. Active trading may not be suitable for individuals with limited resources, investment experience, or a low-risk tolerance. Your capital is at risk.

Please note that StocksRunner and its affiliates ("TS") do not offer, solicit, or endorse securities, derivatives, investment advice, or strategies of any kind. This information is for illustrative purposes only. Do not rely on it for investment decisions. Before making any investment, we recommend considering its appropriateness for your situation and seeking relevant financial, tax, and legal advice.

 
 
StocksRunner logo
 
 
StocksRunner
 
 
StocksRunner
Overview
 
StocksRunner
Trending
 
StocksRunner
Screener
 
StocksRunner
Ideas
 
StocksRunner
Top Rated
 
StocksRunner
Momentum
 
StocksRunner
Earnings
 
 

Most Trending

 
 
 
 
Top Banner
 
 
 
 
 

Top Upgrades in the Headlines

 
 
 
 

AeroVironment upgraded at Jefferies on BlueHalo acquisition.

10 Hours Ago

 
 
 

 

AstraZeneca raised to neutral at UBS despite China headwinds.

13 Hours Ago

 
 
 

 

All You Need to Know About Bio-Path (BPTH) Rating Upgrade to Buy. Bio-Path (BPTH) has been upgraded to a Zacks Rank #2 (Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.

9 Hours Ago

 
 
 

 

All You Need to Know About Bio-Path (BPTH) Rating Upgrade to Buy. Bio-Path (BPTH) has been upgraded to a Zacks Rank #2 (Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.

9 Hours Ago

 
 
 

 

All You Need to Know About Bio-Path (BPTH) Rating Upgrade to Buy. Bio-Path (BPTH) has been upgraded to a Zacks Rank #2 (Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.

9 Hours Ago

 
 
 

 

Chewys opportunity for significant earnings growth earns a double-upgrade at BofA Securities.

10 Hours Ago

 
 
 

 

Chewy double-upgraded to Buy at BofA shares up.

12 Hours Ago

 
 
 

 

Is CVS Health Stock an Underrated Buy?. Shares of healthcare giant CVS Health (NYSE: CVS) have been in a free fall this year. The company has failed to impress investors with its earnings numbers and has slashed its guidance multiple times. It has also m

12 Hours Ago

 
 
 

 

GlobalFoundries and United States Department of Commerce Announce Award Agreement on CHIPS Act Funding for Essential Chip Manufacturing. Up to $1.5 billion from CHIPS and Science Act to support GF'.s New York expansion plans and Vermont facility moder

13 Hours Ago

 
 
 

 

Guardant Health Stock Sees RS Rating Jump To 83. A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.The post Guardant Health Stock Sees RS Rating Jump To 83 appeared first on Investor'.s Business Daily.

6 Hours Ago

 
 
 

 

Guardant Health Stock Sees RS Rating Jump To 83. A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.The post Guardant Health Stock Sees RS Rating Jump To 83 appeared first on Investor'.s Business Daily.

6 Hours Ago

 
 
 

 

Gaming and Leisure Properties upgraded at Deutsche Bank on robust pipeline.

10 Hours Ago

 
 
 

 

Inspire Medical upped to buy by BoA improved margins cited.

7 Hours Ago

 
 
 

 

Inspire Medicals Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade. ) and says the company now falls in the profitable growth category.Inspire Medical is expected to give its 2025 revenue guidance in early January likely alongside it

7 Hours Ago

 
 
 

 

Lemonade upgraded to Equal-weight at Morgan Stanley after investor day targets.

13 Hours Ago

 
 
 

 

Morgan Stanley upgrades insurer Lemonade to equal-weight.

7 Hours Ago

 
 
 

 

Logitech slips even as UBS upgrades on balanced risk-reward.

7 Hours Ago

 
 
 

 

RxSight (RXST) Upgraded to Buy: Heres What You Should Know. RxSight (RXST) has been upgraded to a Zacks Rank #2 (Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.

9 Hours Ago

 
 
 

 

Toast lands Buy rating from Compass on market share gains.

6 Hours Ago

 
 
 

 

Toast lands Buy rating from Compass on market share gains.

6 Hours Ago

 
 
 

 

VNET Reports Unaudited Third Quarter 2024 Financial Results. ) (".VNET". or the ".Company".) a leading carrier- and cloud-neutral internet data center services provider in ".We achieved strong third quarter results mainly driven by our whol

4 Hours Ago

 
 
 

 

Scotiabank Initiates Coverage of Workday (WDAY) with Sector Outperform Recommendation. Fintel reports that on November 18 2024 Scotiabank initiated coverage of Workday (NasdaqGS:WDAY) with a Sector Outperform recommendation.

2 Hours Ago

 
 
 

 

Walmart Posts Q3 Sales Beat Raises Guidance: Analysts Expect Strong Earnings Growth Ahead. Here are some key takeaways from analyst coverage of ) after the retailer reported upbeat third-quarter sales.Goldman Sachs maintained a Buy rating while raising t

7 Hours Ago

 
 
 

 

Israel-Based Cargo Shipping Company ZIM Integrated Smashes Estimates With 626% EBITDA Growth Upgrades 2024 Outlook. ) shares are trading higher after it reported athird-quarter sales increase of117% year over year to$2.77billionbeating.Revenue was driven

12 Hours Ago

 
 
 

 
 
 
 
 
StocksRunner

Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stocks analysis

Stocks trends

Stocks performance

Stocks analysis

Investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.